Skip to main content
Publications
Pladevall-Vila M, Ziemiecki R , Johannes CB , Khan AM , Mines D, Ebert N, Kovesdy CP, Thomsen RW, Baak BN, Garcia-Sempere A, Kanegae H, Coleman CI, Walsh M, Andersen IT, Bernal CR, Cabaninas CR, Christiansen CF, Farjat AE, Gay A, Gee P, Herings RMC, Hurtado I, Kashihara N, Kristensen FPB, Liu F, Okami S, Overbeek JA, Beest FJAP, Yamashita S, Yano Y, Layton JB , Vizcaya D, Oberprieler NG. Clinical profile and treatment patterns in individuals with type 2 diabetes and chronic kidney disease who initiate a GLP-1 receptor agonist: a multinational cohort study . Diabetes Ther. 2025 May;16(5):931-54. doi: 10.1007/s13300-025-01717-8
Jedynak P, Bustamante M, Rolland M, Mustieles V, Thomsen C, Sakhi AK, Sabaredzovic A, Foraster M , Gascon M, Gomez-Roig MD, Llurba E, Rivas I, Ouellet-Morin I, Bayat S, Lyon-Caen S, Pozo OJ, Vrijheid M, Sunyer J, Slama R, Dadvand P, Philippat C. Prenatal exposure to synthetic phenols assessed in multiple urine samples and dysregulation of steroid hormone homeostasis in two European cohorts . Environ Health Perspect. 2025 Mar 21. doi: 10.1289/EHP15117
Zubizarreta-Arruti U, Bosch R, Soler Artigas M, Cabana-Dominguez J, Llonga N, Carabi-Gassol P, Macias-Chimborazo V, Vilar-Ribo L, Ramos-Quiroga JA, Pagerols M, Prat R, Rivas C, Pagespetit E, Puigbo J, Espanol-Martin G, Raimbault B, Valentin A, Sunyer J, Foraster M , Gascon M, Casas M, Ribases M, Alemany S. Associations between air pollution and surrounding greenness with internalizing and externalizing behaviors among schoolchildren . Child Adolesc Ment Health. 2025 Mar 21. doi: 10.1111/camh.12772
Aguilar-Lacasana S, Cosin-Tomas M, Raimbault B, Gomez-Herrera L, Sanchez O, Zanini MJ, Capdevila RP, Foraster M , Gascon M, Rivas I, Llurba E, Gomez-Roig MD, Sunyer J, Bustamante M, Vrijheid M, Dadvand P. Epigenome-wide association study of pregnancy exposure to green space and placental DNA methylation . Environ Res. 2025 Mar 4;274:121286. doi: 10.1016/j.envres.2025.121286
Kovesdy CP, Ebert N, Vizcaya D, Walsh M, Kosiborod MN, Layton JB , Ziemiecki R , Johannes CB , Pladevall-Vila M, Gee PO, Jefferson N, Chicoye A, Lopes M, Thapa BB, Curhan G, Rangel L, Bhartia M, Liu F, Farjat AE, Oberprieler NG. Change in urine albumin-creatinine ratio and occurrence of hyperkalemia in patients initiating finerenone in the United States: a cohort study from the FOUNTAIN platform . Nephron. 2025 Feb 27;1-26. doi: 10.1159/000543923
Weisel K, Mateos MV, Landgren O, Leleu X, Quach H, Bennett L , Talpes M, Majer I, Patel S, Usmani SZ. Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with carfilzomib, dexamethasone, and daratumumab versus carflizomib and dexamethasone: an analysis of patient-reported outcomes from the phase 3 CANDOR trial . Clin Lymphoma Myeloma Leuk. 2025 Feb 19. doi: 10.1016/j.clml.2025.02.005
Johannes CB , Ziemiecki R , Pladevall-Vila M, Ebert N, Kovesdy CP, Thomsen RW, Baak BN, Garcia-Sempere A, Kanegae H, Coleman CI, Walsh M, Andersen IT, Rodriguez Bernal C, Robles Cabaninas C, Christiansen CF, Farjat AE, Gay A, Gee P, Herings RMC, Hurtado I, Kashihara N, Kristensen FPB, Liu F, Okami S, Overbeek JA, Penning-van Beest FJA, Yamashita S, Yano Y, Layton JB , Vizcaya D, Oberprieler NG. Clinical profile and treatment adherence in patients with type 2 diabetes and chronic kidney disease who initiate an SGLT2 inhibitor: a multi-cohort study . Diabetes Ther. 2025 Feb;16(2):205-26. doi: 10.1007/s13300-024-01671-x
Abellan A , Burn E, Trinh NTH, Burkard T, Callahan A, Fernandez-Bertolin S, Hurley E, Rodriguez C, Segundo E, Morales DR, M E Nordeng H, Duarte-Salles T. Expanding the OMOP common data model to support perinatal research in network studies . Pharmacoepidemiol Drug Saf. 2025 Feb;34(2):e70106. doi: 10.1002/pds.70106
Hellwig K, Magyari M, MacDonald TM, Cesta CE, Wergeland S, Leinonen MK, Ornoy A, Vukusic S, Lauer A, Zhou X , Kawai A , Weinrib R , Arana A , Boumenna T. A multi-country cohort database study to assess pregnancy and infant outcomes after potential maternal or paternal exposure to cladribine tablets in the treatment of multiple sclerosis: the CLEAR study methods and status update1 . Ther Adv Neurol Disord. 2025 Jan 27;18:175628642. doi: 10.1177/17562864241310996
Ahn JH, da Silva Pedrosa M, Lopez LR , Tibbs TN , Jeyachandran JN, Vignieri EE, Rothemich A, Cumming I, Irmscher AD, Haswell CJ, Zamboni WC, Yu YA, Ellermann M, Denson LA, Arthur JC. Intestinal E. coli-produced yersiniabactin promotes profibrotic macrophages in Crohn's disease . Cell Host Microbe. 2025 Jan 8;33(1):71-88.e9. doi: 10.1016/j.chom.2024.11.012
Samuelsson K, Rivas I, Raimbault B, Dominguez A, Galmes T, Valentin A, Foraster M , Gascon M, Persavento C, Psyllidis A, Gomez Roig MD, Olive EL, Nieuwenhuijsen MJ, Helbich M, Sunyer J, Dadvand P. A comprehensive GPS-based analysis of activity spaces in early and late pregnancy using the ActMAP framework . Health Place. 2025 Jan;91:103413. doi: 10.1016/j.healthplace.2025.103413
Pistillo A, Warkentin S, Abellan A , de Bont J, Ranger T, Perez-Crespo L, Cirach M, Perramon-Malavez A, Khalid S, Nieuwenhuijsen M, Vrijheid M, Duarte-Salles T. Residential relocation and changes in patterns of environmental exposures by health determinants among children and adolescents in Catalonia, Spain . Environ Res. 2024 Dec 15;263(Pt 2):120152. doi: 10.1016/j.envres.2024.120152
Rao S , McQuay L, Forns J , MacKay R , Aquilina T, Doshi D, Abler V, Anthony MS , Layton B . Mortality in patients with Parkinson's disease psychosis using pimavanserin versus other antipsychotics . Poster presented at the 2024 Parkinson Study Group (PSG) 33rd Annual Meeting; December 5, 2024. Nashville, TN. Previously presented at the Neuroscience Education Institute (NEI) Congress 2024.
Wainberg ZA, Enzinger PC, Qin S, Yamaguchi K, Wang J , Zhou X , Gnanasakthy A , Taylor K, Yusuf A, Maher I, Jamotte A, Kang YK. Health-related quality of life with bemarituzumab plus mFOLFOX6 in patients with FGFR2b-overexpressing, advanced gastric or gastroesophageal junction cancer . ESMO gastrointestinal oncology. 2024 Dec;6. doi: 10.1016/j.esmogo.2024.100095
Dominguez A, Dadvand P, Cirach M, Arevalo G, Barril L, Foraster M , Gascon M, Raimbault B, Galmes T, Gomez-Herrera L, Persavento C, Samuelsson K, Lao J, Moreno T, Querol X, Jerrett M, Schwartz J, Tonne C, Nieuwenhuijsen MJ, Sunyer J, Basagana X, Rivas I. Development of land use regression, dispersion, and hybrid models for prediction of outdoor air pollution exposure in Barcelona . Sci Total Environ. 2024 Dec 1;954:176632. doi: 10.1016/j.scitotenv.2024.176632
Rao S , McQuay L, Forns J , MacKay R , Aquilina T, Doshi D, Abler V, Anthony MS , Layton B . Mortality in patients with Parkinson's disease psychosis using pimavanserin versus other antipsychotics . Poster presented at the Neuroscience Education Institute (NEI) Congress 2024; November 8, 2024. Colorado Springs, CO.
Knox B, Guil-Oumrait N, Basagana X, Cserbik D, Dadvand P, Foraster M , Galmes T, Gascon M, Dolores Gomez-Roig M, Gomez-Herrera L, Smastuen Haug L, Llurba E, Marquez S, Rivas I, Sunyer J, Thomsen C, Julia Zanini M, Bustamante M, Vrijheid M. Prenatal exposure to per- and polyfluoroalkyl substances, fetoplacental hemodynamics, and fetal growth . Environ Int. 2024 Nov;193:109090. doi: 10.1016/j.envint.2024.109090
Xie J, Lopez-Guell K, Dedman D, Duarte-Salles T, Kolde R, Lopez-Blasco R, Martinez A, Mercier G, Abellan A , Arinze JT, Cuccu Z, Delmestri A, Delseny D, Khalid S, Kim C, Kim JW, Kostka K, Loste C, Mateu L, Mayer MA, Melendez-Cardiel J, Mercade-Besora N, Mosseveld M, Nishimura A, Nordeng HME, Oyinlola JO, Perez-Crespo L, Pineda-Moncusi M, Ramirez-Anguita JM, Trinh NTH, Uuskula A, Valdivieso B, Burkard T, Burn E, Catala M, Prieto-Alhambra D, Paredes R, Jodicke AM. Incidence of post-acute COVID-19 symptoms across healthcare settings in seven countries: an international retrospective cohort study using routinely-collected data . EClinicalMedicine. 2024 Oct 30;77(102903). doi: 10.1016/j.eclinm.2024.102903
Rao S , McQuay L, Forns J , MacKay R , Aquilina T, Doshi D, Abler V, Anthony MS , Layton B . Comparing the mortality risk of patients on FDA-approved treatment for Parkinson's disease psychosis, pimavanserin, vs other antipsychotics . Poster presented at the 37th Annual Psych Congress; October 29, 2024. Boston, MA. Previously presented at the Neuroscience Education Institute (NEI) Congress 2024.
Kovesdy CP, Layton JB , Thapa BB, Curhan GC, Rangel LM, Farjat AE, Liu F, Johannes CB , Vizcaya D, Oberprieler NG. Reduction in Urinary Albumin-to-Creatinine Ratio (UACR) in people with CKD and type 2 diabetes initiating finerenone: a CKD stage subgroup analysis from the FOUNTAIN platform . Poster presented at the American Society of Nephrology (ASN) Kidney Week 2024; October 25, 2024. San Diego, CA. [abstract] J Am Soc Nephrol. 2024 Oct; 35(Suppl v1):559.
Kovesdy CP, Layton JB , Thapa BB, Curhan GC, Rangel LM, Farjat AE, Liu F, Johannes CB , Vizcaya D, Oberprieler NG. Reduction in Urinary Albumin-to-Creatinine Ratio (UACR) in people with CKD and type 2 diabetes initiating finerenone: a comedication subgroup analysis from the FOUNTAIN platform . Poster presented at the American Society of Nephrology (ASN) Kidney Week 2024; October 24, 2024. San Diego, CA. [abstract] J Am Soc Nephrol. 2024 Oct; 35(Suppl v1):559.
Ayoub I, Bensink ME, Zhou X , Wang J , Gong W, Preciado P, Komers R, Inrig JK, Rheault MN, Tachtman H. Patient-reported outcomes in adults with FSGS: sparsentan vs. irbesartan . Poster presented at the American Society of Nephrology (ASN) Kidney Week 2024; October 23, 2024. San Diego, CA. [abstract] J Am Soc Nephrol. 2024 Oct; 35(Suppl v1):281.
Wadhwani S, Bensink M, Peipert JD, Ayoub I, Preciado P, Garbinsky D , Wang J , Choi J , Bennett L , Gong W, Inrig J, Komers R. Patient-reported outcomes in the PROTECT clinical trial comparing sparsentan with irbesartan for IgA nephropathy . Poster presented at the American Society of Nephrology (ASN) Kidney Week 2024; October 23, 2024. San Diego, CA. [abstract] J Am Soc Nephrol. 2024 Oct; 35(Suppl v1):723.
Tonne C, Ranzani O, Alari A, Ballester J, Basagana X, Chaccour C, Dadvand P, Duarte T, Foraster M , Mila C, Nieuwenhuijsen MJ, Olmos S, Rico A, Sunyer J, Valentin A, Vivanco R. Air pollution in relation to COVID-19 morbidity and mortality: a large population-based cohort study in Catalonia, Spain (COVAIR-CAT) . Res Rep Health Eff Inst. 2024 Sep;2024(220):1-48.
Haug U, Morales DR, Ehrenstein V, Esen BO, Didelez V, Schafer W, Reinbold J, Martinez D , Garcia de Albeniz X , Gini R, Ryan O, Young J. Target trial emulation with real world evidence: regulatory grade pharmacoepidemiology in the SIGMA consortium . Presented at the 2024 ISPE Annual Meeting; August 28, 2024. Berlin, Germany.
Girardi A, Limoncella G, Hyeraci G, Roberto G, Bartolini C, Paoletti O, Messina D, Villalobos F, Bissacco C, Van den Burg J, Houben E, Santaca k, Lentile V, Ingrasciotta Y, Trifiro G, Hoxhaj V, Duran C, Riera-Arnau J, Garcia P, Martin-Perez M, Huerta-Alvarez C, Llorente-Garcia A, Sanchez-Saez F, Rodriguez-Bernal C, Lassalle R, Jove J, Bernard M, Thurin N, Jordan S, Thayer D, Evans H, Coldea A, Manfrini M, Van Gelder M, Hayati S, Schink T, Tari M, Pajouheshnia R , Afonso A, Noan-Laine M, Molgaard-Nielsen D, Cunnington M, Dodd C, Sturkenboom M, Nordeng H, Gini R. Impact of data source diversity on the distribution of key variables in pregnancy cohorts based on the ConcePTION pregnancy algorithm leveraging a random forest imputation model . Presented at the 2024 ISPE Annual Meeting; August 28, 2024. Berlin, Germany.
Mayer SE, Kawai A , Fuller CC, Agan AA, Rao S , Koram N, Calingaert B , Marshall J, Connolly JG, Moyneur E, Jamal-allial A, Brown J, Burk J, Chomistek A, Daniels K, Dea K, DeFor TA, Diessner B, Djibo DA, Ezzy S, Hawrusik R, Johannes CB , Kendrick K, Layton JB , Ma Q, Mai X, Mack M, Pawloski PA, Reynolds JS, Selvan M, Sharma V, Vetter J, McMahill-Walraven CN, Platt R, Gilsenan A . Interim utilization results from a post-approval safety study of Pfizer-BioNTech monovalent COVID-19 vaccine in the United States . Poster presented at the 2024 ISPE Annual Meeting; August 28, 2024. Berlin, Germany.
Danysh HE , Gilsenan A , Kaye JA, Garcia de Albeniz Martinez X , Schmid R, Bartsch J , Calingaert B , Rahman S, Layton JB , Gutierrez L . Validation of algorithms to identify breast cancer and bladder cancer among patients with type 2 diabetes mellitus in United States medicare administrative claims . Poster presented at the 2024 ISPE Annual Meeting; August 28, 2024. Berlin, Germany.
Layton JB , Muthuri S, Lindaas A, Lloyd PC, Richey MM, Gruber JF, Clarke TC, Kowarski LS, McKillop M, Fisher S, Lyu H, Cheng A, Bui CL , Duenas PF, Chen Y, Forshee RA, Anderson SA, Beers JB, Burrell T, Chillarige Y, Anthony MS , Shoaibi A. Risk of neurologic or immune-mediated adverse events after COVID-19 diagnosis in the United States . Presented at the 2024 ISPE Annual Meeting; August 28, 2024. Berlin, Germany.